Cargando…
Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
Autores principales: | Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., van de Vijver, M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643603/ https://www.ncbi.nlm.nih.gov/pubmed/26105796 http://dx.doi.org/10.1007/s10549-015-3478-0 |
Ejemplares similares
-
Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015) -
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
por: Dekker, Tim JA, et al.
Publicado: (2012) -
Expression of progesterone receptor in human keratinocytes.
por: Im, S., et al.
Publicado: (2000) -
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material
por: Berghuis, A. M. Sofie, et al.
Publicado: (2019) -
Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
por: Savci-Heijink, C. D., et al.
Publicado: (2019)